We present the development of a two-component magnetic resonance (MR) fiducial system, that is, a fiducial marker device combined with an auto-segmentation algorithm, designed to be paired with existing ultrasound probe tracking and image fusion technology to automatically fuse MR and ultrasound (US) images. The fiducial device consisted of four~6.4 mL cylindrical wells filled with 1 g/L copper sulfate solution. The algorithm was designed to automatically segment the device in clinical abdominal MR images. The algorithm's detection rate and repeatability were investigated through a phantom study and in human volunteers. The detection rate was 100% in all phantom and human images. The center-of-mass of the fiducial device was robustly identified with maximum variations of 2.9 mm in position and 0.9°in angular orientation. In volunteer images, average differences between algorithmmeasured inter-marker spacings and actual separation distances were 0.53 AE 0.36 mm. "Proof-of-concept" automatic MR-US fusions were conducted with sets of images from both a phantom and volunteer using a commercial prototype system, which was built based on the above findings. Image fusion accuracy was measured to be within 5 mm for breath-hold scanning. These results demonstrate the capability of this approach to automatically fuse US and MR images acquired across a wide range of clinical abdominal pulse sequences. very commonly used in the abdomen or pelvis for lesion detection and characterization. However, application of MRI for guidance of percutaneous diagnostic or interventional procedures such as biopsy or thermal ablation remains a challenge due to limited access within the MRI scanner bore and incompatibility of some percutaneous devices with the MRI environment. Instead, ultrasound (US) is more commonly used as a guidance modality because it is widely accessible and portable for use in procedural suites. Moreover, US guidance affords flexibility in angle of approach and allows precise, real-time targeting of lesions in spite of normal respiratory motion. 
Unfortunately, lesions may have low conspicuity with US imaging, particularly in obese patients, in patients with prior chemotherapy treatment or in patients with diffuse parenchymal disease. [1] [2] [3] Thus, fusion or co-registration of real-time US with previously obtained MRI has been advocated for guidance of percutaneous interventions on challenging lesions. MR-US image fusion pairs the advantages of MRI, namely high-contrast resolution and lesion conspicuity, with the real-time capabilities of US guidance, and has been shown to be clinically beneficial. [1] [2] [3] [4] [5] [6] [7] [8] Most current commercial MR-US image fusion applications rely on manual co-registration of images. (One example is General Electric's LOGIQ E9 ultrasound system with Volume Navigation automated registration process. [10] [11] [12] [13] Active fiducial marker devices are limited in that they are complex, are susceptible to radio-frequency heating during MRI, and rely on precise tuning and calibration. 10 On the other hand, recently investigated passive marker systems 10-13 required use of custom or specific MRI pulse sequences with some relying on spatial frequency images 10, 11 or only being limited to specific clinical application (i.e. fixed in headrest for intracranial imaging only). 13 Additional approaches to MR-US fusion without the use of external fiducial markers have also been reported. 14, 15 These methods, however, require either acquisitions of 3D US images combined with extensive computation time and initial manual three-point rigid registration, 14 or have been demonstrated to be successful only with a single MRI pulse sequence. 14, 15 In a proposed system, automated MR-US image fusion works as follows: an MRI fiducial device attached to a patient is imaged in an MR scanner, and subsequently, automatically segmented within the acquired image set. When the patient undergoes a US-guided interventional procedure, an electromagnetic sensor is attached to the fiducial and placed on the patient in the same location as it was during the prior MRI examination. 
| MATERIALS AND METHODS

2.A | Fiducial device prototype
The fiducial marker device was designed with the goal of being detectable in images acquired with the wide array of possible pulse sequences used in our institution's clinical abdominal MRI protocol (Table 1 ). The prototype device, shown in Fig. 1 , consisted of three cylindrical reservoirs with 12.7 mm inner diameter and depth, arranged to form a scalene triangle with the following side lengths:
50.7, 69.2, and 88.9 mm. A fourth reservoir was positioned 12.7 mm above the centroid of the triangle as shown in Fig. 1(a) . Actual marker separation distances were within an estimated tolerance of 1 mm. The reservoirs were filled with 1 g/L (6.265 mM) copper sulfate solution. The location of the device was defined as the centerof-mass of the group of four markers (derived from their individual, intensity-weighted, center-of-mass coordinates), shown in Fig. 1(a) .
The orientation of the device was defined as the cross product of the vectors from marker A to marker B and marker A to marker C, see Fig. 1 (c).
The choice of 1 g/L copper sulfate solution as a fiducial marker material was motivated by published reports indicating this material as suitable for preparation of high-contrast MRI markers. 16, 17 In addition, liquid copper sulfate solutions are readily available and convenient for fabricating custom fiducial markers. The particular selection of the marker size of 12.7 mm took into account the average slice thickness and slice gap of the RF pulse sequences listed in Table 1 : 5-6 mm and 1-2 mm, respectively (Fig. 2 ).
2.B | Segmentation algorithm
Operational steps of the MATLAB â (The MathWorks Inc., Natick, MA, 2000) algorithm used to automatically segment markers from MRI datasets are described below and in Fig. 2 . The empirically determined parameters associated with each step are listed in Table 2 .
2.B.1 | Step 1: Determination of "noise threshold,"
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The purpose of this step is to remove the majority of voxels containing background noise only. A histogram of voxel intensity values (bin size set to single integer and number bins set to the maximum voxel signal), h I ð Þ, is expected to contain a major peak at a low-intensity value, I noise , which is associated with image noise. Additional peaks at higher intensity values, I signal , are associated with MRI signal. As a result, the derivative of the histogram will change sign at some intermediate intensity value, I 0 , between the low-intensity and highintensity peaks. We define the noise threshold as the voxel value corresponding to this zero-crossing of the histogram derivative: 
2.B.4 | Step 4: Shape discrimination
The marker candidates are evaluated based on their shape. Only those with their longest dimension not exceeding 26.9 mm (1.5 times the known longest dimension of original cylindrical marker) are retained; all other candidates are removed.
2.B.5 | Step 5: Inter-marker distance discrimination
In this last step, the algorithm looks for a group of four marker candidates whose intensity-weighted centers-of-mass are separated by distances equal to the physical inter-marker separations of the fiducial device. If four candidates are found fitting that condition within the tolerance of AE1 mm, they are consequently identified as the segmented markers of the fiducial device. Otherwise, the separation tolerance is incrementally increased by 1 mm, and the process is repeated until the four markers are found. Table 1 . The images were collected in three predefined imaging planes: axial (perpendicular to the long axis of the scanner) and two separate oblique planes. The table and the device were then translated 3 cm along the long scanner axis, and similar image sets were acquired. Axial images acquired in the first table position were used as a "baseline" dataset, to which image sets from subsequent acquisitions were compared. For each of the imaging planes, the automated segmentation algorithm was used to detect and segment the markers, as described earlier in the Section 2.B, and subsequently, the position of the fiducial markers' center-of-mass and the device orientation (i.e. the orientation of the vector normal the base) was determined, as shown in Fig. 1 . The positions of the translated device obtained using the axial and oblique acquisitions were compared with those of the baseline acquisitions, and the relative displacements were computed. Similarly, the device orientation angles (including those for translated device) determined using oblique acquisitions were then compared with those from the baseline measurements and the angular differences were calculated.
2.C.2. | Volunteer trials
The fiducial device was imaged on five volunteers (three males, two females) of different ages and body habitus. Eight sets of images were acquired for each volunteer using the aforementioned MRI scanner, 8-channel torso coil, and the abdominal pulse sequences from the clinical abdominal protocol listed in Table 1 . Following image acquisition, the four markers comprising the fiducial device were individually segmented with our algorithm, and inter-marker spacings were calculated.
T A B L E 2 Segmentation algorithm parameters. (GE Healthcare, Wauwatosa, WI) with a LAVA pulse sequence and using GE-default acquisition parameters similar to those listed in Table 1 . US imaging sessions were performed on the phantom and the volunteer 1 day after the acquisition of MR images. In phantom experiments, the fiducial device was permanently affixed to the phantom for both MR and US imaging. In the volunteer experiments, the position of the fiducial device was marked on the volunteer's skin with ink prior to the MRI scans, and a fiducial device was placed on the volunteer at the marked location for US imaging.
For both the phantom and volunteer experiments, an electromagnetic tracking sensor, which tracks the position and orientation of the ultrasound probe, was affixed to the MRI fiducial device as depicted in Fig. 3(b) . This tracking device is one element of the Volume Navigation component that is integrated with the US scanner.
For each experiment, the MR image set was loaded onto the US scanner and then processed by the auto-segmentation algorithm. T A B L E 3 Device location in the initial, baseline acquisition, and differences in measured device location between different acquisitions and the baseline acquisition. The device centers-of-mass are given in the LPS patient coordinate system and in units of millimeters.
Pulse sequence Dimension
Position (mm) Position difference (mm) All of the markers were accurately segmented in all of the images. The average difference between the actual and image-derived marker centers-of-mass spacings was 0.41 AE 0.37 mm among all images acquired with both SPGR and FR-FSE pulse sequences. Table 3 shows the center-of-mass coordinates calculated based on the baseline acquisition and compares them with those calculated based on acquisitions using oblique scanning planes and translated device, as described in Section 2.C.1. The coordinate differences shown in Table 3 corresponds to average differences in center-of-mass locations of 1.4 (SPGR) and 2.1 mm (FR-FSE) and maximum differences of 1.9 (SPGR) and 2.9 mm (FR-FSE). Similarly, Table 4 shows orientation angles for the initial, baseline acquisition, and differences in measured orientation angles between the different acquisitions and the baseline acquisition. Angle differences are given for all combinations of MRI sequence, translation, and oblique angulation. The repeatability of the angular measurements is, thus, represented by the maximum absolute angular differences of 0.6°(SPGR) and 0.9°(FR-FSE).
3.A.2. | Volunteer trials
Each of the four markers on the device was accurately segmented for all volunteers and image sets. No false positives were recorded.
An example set of segmentation results is shown in Fig. 4 . To validate the accuracy of the determined marker location and orientation, the algorithm-based separation measurements were compared with the known, actual inter-marker separation distances. Average separation distance differences were determined across all volunteers. The global average of absolute separation differences was 0.53 AE 0.36 mm. This value includes all pulse sequences, all marker separation distances, and all volunteers. Separation distances averaged for each unique marker spacing were also examined. In addition, the differences in absolute position of the fiducial device, as compared with the device position in the LAVA image set, were computed. Results are shown in Table 5 .
3.C. | Proof-of-concept
Using the integrated, commercial system, the fiducial device was located with the auto-segmentation algorithm in both the phantom and volunteer experiments. MR-US fused images were immediately displayed following auto-registration. Example screen capture images are shown in Fig. 5 . In the fused phantom images, user-identified T A B L E 4 Orientation angles for the initial, baseline acquisition, and differences in measured orientation angles between the different acquisitions and the baseline acquisition. The device was placed on a level base, so the anticipated orientation angles were (90#-90û). The direction cosines are listed for each unique acquisition. | 269 patient, and general workflow-specific to a given clinical practicewould greatly aid the successful implementation of this system.
Although tests of this system were successful, the following future developments of this system could improve its robustness and clinical applicability. The algorithm can be modified to find the center-of-mass of the device if only three markers are successfully segmented. Moreover, an option for user input to identify the location of the markers would mitigate a complete failure to segment the markers. In addition, different device shapes and marker sizes could be tailored for specific applications. The device in this investigation was designed with abdominal applications in mind. For instance, smaller markers (and a smaller device footprint) could be used for MRI examinations that reconstruct thinner slices with thinner slice gaps. Also, all image acquisitions from the entire examination could be determined and averaged with appropriate (resolution-based) weighting factors applied for each sequence, which could possibly provide more accurate localization and further reduce the likelihood of localization failure. Lastly, this system could be combined with deformable image registration techniques that require an initial three-point registration of the images, 14 in which case this system would provide the necessary initial global rigid registration.
| CONCLUSION
The work presented in this report demonstrates that the two-component MRI fiducial marker system (passive fiducial device coupled with the detection algorithm) enables robust, accurate, and reliable detection and localization of the fiducial device within MR image sets. Moreover, the proof-of-concept experiments demonstrate that implementation of this automatic MR-US image fusion approach on clinical US scanners is possible and results in accurately fused images readily displayed on an ultrasound scanner display.
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